Literature DB >> 2010773

Medulloblastoma: a population-based study of 532 cases.

R O Roberts1, C F Lynch, M P Jones, M N Hart.   

Abstract

Five hundred thirty-two cases of medulloblastoma (males n = 327 and females n = 205), aged 0 to 86 years diagnosed between 1973 and 1986 were studied to determine the incidence in different geographic regions of the United States and to evaluate the effect of various factors on survival. The median age was 9 years and average follow-up time was 45 months. The overall incidence rate was 1.8 per one million person-years. Variables that were statistically significant (p less than 0.05) in a multivariate model determining survival in rank order were treatment group, sex, geographic region, year group and age. This observational study found that 1) age and sex were statistically significant factors in describing the incidence rates, whereas year group and geographic region were not; 2) no incidence peak in the third decade of life was observed; 3) a significant improvement in survival was observed in the combined 1978 to 1986 year groups relative to the 1973 to 1977 year group; 4) the overall 5-year survival probability was 45%; and 5) there has been an increase over time in the use of more than two modalities of treatment.

Entities:  

Mesh:

Year:  1991        PMID: 2010773     DOI: 10.1097/00005072-199103000-00005

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  32 in total

1.  Outcome of children with posterior fossa medulloblastoma: a single institution experience over the decade 1994-2003.

Authors:  D Kombogiorgas; S Sgouros; A R Walsh; A D Hockley; M Stevens; R Grundy; A Peet; M English; D Spooner
Journal:  Childs Nerv Syst       Date:  2006-11-22       Impact factor: 1.475

2.  Appraisal of the current staging system for residual medulloblastoma by volumetric analysis.

Authors:  Dimitris Kombogiorgas; Stephanie Puget; Nathalie Boddaert; Andrew Peet; Martin English; Kal Natarajan; Jacques Grill; Dominique Couanet; Christian Sainte-Rose; Spyros Sgouros
Journal:  Childs Nerv Syst       Date:  2011-08-04       Impact factor: 1.475

Review 3.  The radiation treatment of medulloblastoma.

Authors:  D Jenkin
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

4.  Primary Sonic Hedgehog-activated dorsal brainstem medulloblastoma and ipsilateral cerebellar atrophy in an adult.

Authors:  Mustafa Kemal Demir; Özlem Yapıcıer; Basak Mert; Wiaam Alshareefi; Mustafa Bozbuğa
Journal:  Neuroradiol J       Date:  2019-11-27

Review 5.  Medulloblastoma: atypical CT and MRI findings in children.

Authors:  Ayelet Eran; Arzu Ozturk; Nafi Aygun; Izlem Izbudak
Journal:  Pediatr Radiol       Date:  2010-04-13

6.  Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas.

Authors:  B Krynska; L Del Valle; S Croul; J Gordon; C D Katsetos; M Carbone; A Giordano; K Khalili
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

7.  Survival in pediatric medulloblastoma: a population-based observational study to improve prognostication.

Authors:  Alexander G Weil; Anthony C Wang; Harrison J Westwick; George M Ibrahim; Rojine T Ariani; Louis Crevier; Sebastien Perreault; Tom Davidson; Chi-Hong Tseng; Aria Fallah
Journal:  J Neurooncol       Date:  2016-12-15       Impact factor: 4.130

8.  Survivin expression in medulloblastoma: a possible marker for survival.

Authors:  Azza Abdel-Aziz; Mie Ali Ali Mohamed; Fatma Mohamed Farouk Akl; Ahmed Nageeb M Taha
Journal:  Pathol Oncol Res       Date:  2012-12-16       Impact factor: 3.201

9.  Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index.

Authors:  Chitra Sarkar; Pulakesh Pramanik; Asis Kumar Karak; Partho Mukhopadhyay; Mehar Chand Sharma; Varindera Paul Singh; Veer Singh Mehta
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

10.  A novel role of HLA class I in the pathology of medulloblastoma.

Authors:  Courtney Smith; Mariarita Santi; Bhargavi Rajan; Elisabeth J Rushing; Mi Rim Choi; Brian R Rood; Robert Cornelison; Tobey J MacDonald; Stanislav Vukmanovic
Journal:  J Transl Med       Date:  2009-07-12       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.